cbdMD (YCBD) Cyclically Adjusted FCF per Share: $-153.66 (As of Mar. 2026)


YCBD cbdMD Inc YCBD
39 GF Score
Price $0.72
GF Value $0.16
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is cbdMD Cyclically Adjusted FCF per Share?

cbdMD YCBD -3.09% 39 Cyclically Adjusted FCF per Share is $-153.66 as of Mar. 2026. GuruFocus rates YCBD with a GF Score™ of 39/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

cbdMD's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.070. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-153.66 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-08), cbdMD's current stock price is $0.7151. cbdMD's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-153.66. cbdMD's Cyclically Adjusted Price-to-FCF of today is .


cbdMD  (AMEX:YCBD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


cbdMD Cyclically Adjusted FCF per Share Related Terms


cbdMD Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for cbdMD's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

cbdMD Cyclically Adjusted FCF per Share Chart

cbdMD Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

cbdMD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -154.76 -153.66

YCBD vs AKAN, GELS, SNOA: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where cbdMD's Cyclically Adjusted Price-to-FCF falls into.


YCBD
39GF Score
cbdMD Inc YCBD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

cbdMD Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, cbdMD's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.07/330.2130*330.2130
=-0.070

Current CPI (Mar. 2026) = 330.2130.

cbdMD Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.000 241.018 0.000
201609 -36.385 241.428 -49.766
201612 -41.231 241.432 -56.393
201703 -58.692 243.801 -79.495
201706 -10.308 244.955 -13.896
201709 -43.095 246.819 -57.656
201712 -96.000 246.524 -128.590
201803 -95.091 249.554 -125.826
201806 -58.545 251.989 -76.719
201809 -32.783 252.439 -42.883
201812 -44.750 251.233 -58.818
201903 -121.107 254.202 -157.320
201906 -75.781 256.143 -97.695
201909 -92.610 256.759 -119.104
201912 -68.734 256.974 -88.324
202003 -53.029 258.115 -67.841
202006 -8.287 257.797 -10.615
202009 0.986 260.280 1.251
202012 -15.759 260.474 -19.978
202103 -20.752 264.877 -25.871
202106 -27.444 271.696 -33.355
202109 -39.775 274.310 -47.881
202112 -35.398 278.802 -41.925
202203 -32.591 287.504 -37.432
202206 -14.903 296.311 -16.608
202209 -12.659 296.808 -14.084
202212 -13.339 296.797 -14.841
202303 -9.714 301.836 -10.627
202306 -1.155 305.109 -1.250
202309 -1.038 307.789 -1.114
202312 -0.786 306.746 -0.846
202403 -1.889 312.332 -1.997
202406 0.646 314.175 0.679
202409 0.116 315.301 0.121
202412 -0.847 315.605 -0.886
202503 -0.263 319.799 -0.272
202506 -0.122 322.561 -0.125
202509 -0.027 324.800 -0.027
202512 -0.109 324.054 -0.111
202603 -0.070 330.213 -0.070

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-153.66 mean?
cbdMD (YCBD) has a Cyclically Adjusted FCF per Share of $-153.66 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on cbdMD and its competitors.
Is cbdMD's Cyclically Adjusted FCF per Share too high?
cbdMD's current Cyclically Adjusted FCF per Share is $-153.66. Overall, cbdMD has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's Cyclically Adjusted FCF per Share compare to AKAN and GELS?
cbdMD's Cyclically Adjusted FCF per Share of $-153.66 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on cbdMD and its competitors. cbdMD's current Cyclically Adjusted FCF per Share is $-153.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.72 — trading 346.9% above its estimated fair value. The current Cyclically Adjusted FCF per Share is $-153.66. cbdMD's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For cbdMD (YCBD), the current Cyclically Adjusted FCF per Share is $-153.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is cbdMD (YCBD) Overvalued in 2026?

Based on GuruFocus' analysis, cbdMD stock appears to be overvalued. The current stock price of $0.72 is trading 346.9% above its estimated GF Value™ of $0.16. GuruFocus considers cbdMD to be Significantly Overvalued.

Key valuation signals for YCBD:

  • Cyclically Adjusted FCF per Share: $-153.66
  • GF Value™: $0.16 vs. price of $0.72 (346.9% above fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


cbdMD Business Description

Address 2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
39GF Score

Get the complete analysis for YCBD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.72
Price
$0.16
GF Value